Verrica Pharmaceuticals Inc (VRCA)
Insider transactions
A complete record of Form 4 filings tracking every share acquisition and disposal by executives, directors, and senior officers. Filterable by date range and transaction type, the table exposes the direct market actions of those with the deepest knowledge of a company's operations — providing a factual, data-driven signal of internal conviction that complements traditional fundamental and technical analysis.
Transaction date | Executive | Executive Title | Security Type | Acquisition / Disposal | Shares | Share price |
|---|---|---|---|---|---|---|
| Aug 18, 2026 | KIRBY, JOHN J. | Interim CFO | Common Stock | Acquisition | 5,000 | 4.93 |
| Aug 18, 2026 | ROSENBERG, NOAH L. | CMO | Common Stock | Acquisition | 2,030 | 4.92 |
| Aug 17, 2026 | RIEGER, JAYSON | Director, CEO and President | Common Stock | Acquisition | 5,000 | 4.91 |
| Aug 17, 2026 | ZAWITZ, DAVID | Chief Operating Officer | Common Stock | Acquisition | 6,000 | 4.98 |
| Aug 17, 2026 | ROSENBERG, NOAH L. | CMO | Common Stock | Acquisition | 4,200 | 4.91 |
| Aug 14, 2026 | RIEGER, JAYSON | Director, CEO and President | Common Stock | Acquisition | 20,000 | 5.06 |
| Jun 5, 2026 | EICHENFIELD, LAWRENCE | Director | Stock Option (right to buy) | Acquisition | 16,000 | 0 |
| Jun 5, 2026 | RIEGER, JAYSON | Director, CEO and President | Employee Stock Option (right to buy) | Acquisition | 512,269 | 0 |
| Jun 5, 2026 | NGUYEN, DIEM | Director | Stock Option (right to buy) | Acquisition | 16,000 | 0 |
| Jun 5, 2026 | PRYGOCKI, MARK A SR | Director | Stock Option (right to buy) | Acquisition | 16,000 | 0 |
| Jun 5, 2026 | ROSENBERG, NOAH L. | CMO | Employee Stock Option (right to buy) | Acquisition | 233,840 | 0 |
| Jun 5, 2026 | ZAWITZ, DAVID | Chief Operating Officer | Employee Stock Option (right to buy) | Acquisition | 171,340 | 0 |
| Jun 5, 2026 | CORCORAN, GAVIN | Director | Stock Option (right to buy) | Acquisition | 16,000 | 0 |
| Dec 23, 2025 | KIRBY, JOHN J. | Interim CFO | Common Stock | Acquisition | 10,000 | 0 |
| Nov 25, 2025 | MANNING, PAUL B | Director, 10% Owner | Common Stock | Acquisition | 1,375,380 | 4.243 |
| Nov 25, 2025 | MANNING, PAUL B | Director, 10% Owner | Common Stock | Acquisition | 2,750,762 | 4.243 |
| Nov 25, 2025 | ROSENBERG, NOAH L. | CMO | Series C Warrant (right to buy) | Acquisition | 589 | |
| Nov 25, 2025 | RIEGER, JAYSON | Director, CEO and President | Common Stock | Acquisition | 94,311 | 4.243 |
| Nov 25, 2025 | MANNING, PAUL B | Director, 10% Owner | Series C Warrant (right to buy) | Acquisition | 343,845 | |
| Nov 25, 2025 | MANNING, PAUL B | Director, 10% Owner | Series C Warrant (right to buy) | Acquisition | 687,690 | |
| Nov 25, 2025 | RIEGER, JAYSON | Director, CEO and President | Series C Warrant (right to buy) | Acquisition | 23,577 | |
| Nov 25, 2025 | KIRBY, JOHN J. | Interim CFO | Common Stock | Acquisition | 3,536 | 4.243 |
| Nov 25, 2025 | ZAWITZ, DAVID | Chief Operating Officer | Series C Warrant (right to buy) | Acquisition | 2,500 | |
| Nov 25, 2025 | ROSENBERG, NOAH L. | CMO | Common Stock | Acquisition | 2,357 | 4.243 |
| Nov 25, 2025 | KIRBY, JOHN J. | Interim CFO | Series C Warrant (right to buy) | Acquisition | 884 | |
| Nov 25, 2025 | ZAWITZ, DAVID | Chief Operating Officer | Common Stock | Acquisition | 10,000 | 4.243 |